Toronto Dominion Bank
TARS icon

Toronto Dominion Bank’s Tarsus Pharmaceuticals TARS Stock Holding History

Toronto Dominion Bank’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$35.8M Hold
510,253
– – 0.05% 294
2025
Q4 		$41.8M Sell
510,253
-107,330
-17% -$8.01M 0.06% 286
2025
Q3 		$36.7M Sell
617,583
-384,379
-38% -$18.9M 0.06% 290
2025
Q2 		$40.6M Sell
1,001,962
-872,783
-47% -$39.3M 0.07% 236
2025
Q1 		$96.3M Sell
1,874,745
-34,483
-2% -$1.7M 0.19% 94
2024
Q4 		$106M Buy
+1,909,228
New +$86.7M 0.17% 92

Other funds holding TARS

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Toronto Dominion Bank's TARS Position: Q1 2026 in Review

Toronto Dominion Bank held its Tarsus Pharmaceuticals (TARS) position steady in Q1 2026 at 510,253 shares worth $35.8M. The position accounts for 0.05% of the portfolio, ranked #294.

Toronto Dominion Bank first reported a position in TARS in Q4 2024 and has held it in 6 quarters since. The position peaked at $106M in Q4 2024. 253 funds tracked by Wall St. Rank hold TARS as of Q1 2026.

  • Toronto Dominion Bank held 510,253 shares of Tarsus Pharmaceuticals worth $35.8M as of Q1 2026.
  • Toronto Dominion Bank left its Tarsus Pharmaceuticals share count unchanged in Q1 2026.
  • Tarsus Pharmaceuticals made up 0.05% of Toronto Dominion Bank's portfolio in Q1 2026, its #294 holding.
  • Toronto Dominion Bank first reported a position in Tarsus Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • Toronto Dominion Bank's Tarsus Pharmaceuticals position peaked at $106M in Q4 2024.
  • 253 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.